The global patent landscape of mRNA for diagnosis and therapy

The COVID-19 pandemic brought mRNA vaccines to market in a short period, pointing the entire drug development field in the direction of mRNA treatment.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature biotechnology 2023-09, Vol.41 (9), p.1193-1199
Hauptverfasser:	Lyu, Mengru, Chen, Jiyuan, Peng, Yeheng, Han, Fang, Gong, Luyao, Guo, Jingfei, Tian, Lijuan, Gao, Yuan
Format:	Artikel
Sprache:	eng
Schlagworte:	631/1647/2300/1514 631/45/500 692/699/255/2514 Agriculture Bioinformatics Biomedical and Life Sciences Biomedical Engineering/Biotechnology Biomedicine Biotechnology Collaboration Coronaviruses COVID-19 COVID-19 vaccines CRISPR Drug development Estoppel Inventors Life Sciences mRNA mRNA vaccines Pandemics Patents as Topic RNA, Messenger Statistical analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The COVID-19 pandemic brought mRNA vaccines to market in a short period, pointing the entire drug development field in the direction of mRNA treatment.
ISSN:	1087-0156 1546-1696 1546-1696
DOI:	10.1038/s41587-023-01925-2